 | Up a level |
McClung, Michael R; O'Donoghue, Michelle L; Papapoulos, Socrates E; Bone, Henry; Langdahl, Bente; Saag, Kenneth G; Reid, Ian R; Kiel, Douglas P; Cavallari, Ilaria; Bonaca, Marc P; Wiviott, Stephen D; de Villiers, Tobias; Ling, Xu; Lippuner, Kurt; Nakamura, Toshitaka; Reginster, Jean-Yves; Rodriguez-Portales, Jose Adolfo; Roux, Christian; Zanchetta, José; Zerbini, Cristiano A F; ... (2019). Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. The lancet. Diabetes & endocrinology, 7(12), pp. 899-911. Elsevier 10.1016/S2213-8587(19)30346-8
Bone, Henry G; Wagman, Rachel B; Brandi, Maria L; Brown, Jacques P; Chapurlat, Roland; Cummings, Steven R; Czerwiński, Edward; Fahrleitner-Pammer, Astrid; Kendler, David L; Lippuner, Kurt; Reginster, Jean-Yves; Roux, Christian; Malouf, Jorge; Bradley, Michelle N; Daizadeh, Nadia S; Wang, Andrea; Dakin, Paula; Pannacciulli, Nicola; Dempster, David W and Papapoulos, Socrates (2017). 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. The lancet. Diabetes & endocrinology, 5(7), pp. 513-523. Elsevier 10.1016/S2213-8587(17)30138-9
